Investigació Aplicada en Malalties Respiratòries


  • Friday, 02/02/2024

    Ana Motos Awarded the Prestigious RESPIRE - MSCA Fellowship

    Dr. Ana Motos, a promising researcher trained in our group in the field of respiratory infections, has been awarded the prestigious RESPIRE - Marie Skłodowska-Curie Actions (MSCA) fellowship. This esteemed grant, funded by the European Respiratory Society and the European Commission, is designed to support groundbreaking research and innovation. Known for its highly competitive selection process, the RESPIRE - MSCA grant provides not only financial support but also access to a vast network of research and training opportunities across Europe.

    With the MSCA grant, Dr. Motos will embark on a two-year research journey at the University of Nantes under the supervision of Prof. Antoine Roquilly. Dr. Motos' project, titled "Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment Failures," aims to define sub-phenotypes of respiratory microbiomes associated with the emergence of resistance during treatment and treatment failure. The project's implications extend beyond the scientific community, as findings may contribute to the development of targeted therapeutic approaches for pneumonia, improving patient outcomes, and addressing antibiotic resistance challenges.


  • Thursday, 02/01/2024

    Kasra Kiarostami publishes Debut Paper as Lead Author

    kasra Kiarostami wants to thanks to Prof. Antoni Torres, Dr. Laia Fernandez, Dr. Ana Motos and all collaborators in the Theravance project the recent article " The efficacy of telavancin in comparison with linezolid on endotracheal tube biofilm in pigs with methicillin-resistant Staphylococcus aureus pneumonia" was published in International Journal of Antimicrobial Agents journal. The first author is kasra Kiarostami.

    In summary, this research compared the efficacy of telavancin and linezolid in addressing biofilms on endotracheal tubes (ETT) in a porcine model simulating methicillin-resistant Staphylococcus aureus (MRSA) ventilator-associated pneumonia (VAP). While MRSA loads on the ETT and cuff did not significantly differ among control, linezolid, and telavancin groups, a notable finding revealed telavancin's ability to reduce MRSA biofilm on the ETT. This suggests potential advantages for telavancin in clinical settings, especially for elective patients. Despite acknowledging the study's limitation of a small sample size, we argue that this model aligns with real-world VAP scenarios in critically ill patients, emphasizing the need for further investigation. The study highlights telavancin's potential significance in combating biofilms and improving treatment approaches for VAP."

    Thank you!


  • Thursday, 02/01/2024

    New Study Coordinator of the Animal Model

    We are delighted to announce that Dr. Flavia Galli has been appointed as the new Research Study Coordinator for our animal model program. With a background in anesthesiology and critical care medicine, Dr. Galli received her medical training at Policlinico Universitario A. Gemelli of Rome, bringing a wealth of expertise to our team.

    Over the past two years, Dr. Galli has contributed significantly to our organization as a clinical research fellow, dedicating her efforts to researching the animal model and spearheading projects related to critically ill patients and COVID-19. Her commitment to advancing medical knowledge and improving patient outcomes has been exemplary.

    In her new role, Dr. Galli will assume responsibility for the design, implementation, and coordination of animal protocols, ensuring the highest standards of scientific rigor. Additionally, she will oversee the analysis of data and scientific production, driving forward innovative research initiatives.

    Furthermore, Dr. Galli will play a pivotal role in facilitating collaboration with incoming international fellows, fostering an environment of knowledge exchange and collaboration.

    Congratulations Flavia!


More news

Subscribe to news